Lonza to expand bioconjugation capabilities at Visp site
CDMO will add two production suites for clinical and commercial supply and extend lab space to double analytical and process development capacity
CDMO Lonza is expanding bioconjugation capabilities at its development and manufacturing site in Visp, Switzerland by adding two production suites providing development and manufacturing infrastructure for clinical and commercial supply as well as extending laboratory space to double the analytical and process development capacity.
The new capacity is expected to be fully operational from the first half of 2022.
The manufacturing extension spans approximately 1500m2 and adds 30% additional capacity while an additional support building of 5000m2 will provide space for logistics, storage and other supporting infrastructure.
Lonza said the “highly flexible” setup will enable bioconjugation processes using single-use, stainless steel and hybrid concepts.
In a statement, Stefan Egli, Head Business Unit Bioconjugates, Lonza, said bioconjugation is used to develop a growing pipeline of complex protein therapeutics such as antibody-drug conjugates (ADCs).
ADcs are a class of biopharmaceutical drugs specifically designed to target and kill tumour cells while sparing healthy ones.
The CDMO said the expansion complements its recent expansion of customer-specific suites as part of the Ibex Dedicate model.
“In addition, expansions in payload manufacturing capacity and drug product sterile fill and finish will support the increasing development and manufacturing needs for bioconjugates,” the company said.
“Lonza started to offer CDMO services for ADCs back in 2006 and we now manufacture the majority of the currently commercially approved ADCs,” said Iwan Bertholjotti, Director Commercial Development Bioconjugates at Lonza. “The field goes beyond ADC’s and Lonza has the expertise to support customers bringing a range of different bioconjugates to market.”
The CDMO said it has produced over 600 cGMP batches of bioconjugated products for over 60 different projects since 2006.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance